盐酸妥拉唑林

  • 基本信息
  • 制备方法及用途
  • 物化性质
  • 安全信息
  • 毒理性
  • MSDS
  • 海关数据
  • 结构与计算化学
  • 表征图谱

盐酸妥拉唑林 基本信息

中文名称:
盐酸妥拉唑林 
中文别名:
盐酸妥拉唑林;
2-苄基咪唑啉;
2-苄基-2-咪唑啉 盐酸盐 
英文名称:
1H-Imidazole,4,5-dihydro-2-(phenylmethyl)-, hydrochloride (1:1)
英文别名:
Tolazoline hydrochloride;
2-benzyl-4,5-dihydro-1H-imidazole,hydrochloride 
CAS No.:
59-97-2
分 子 式:
C10H12N2.ClH
分 子 量:
196.7
精确分子量:
196.07700
PSA:
24.39000
MDL:
MFCD00012693
EINECS:
200-447-3
InChI:
InChI=1/C10H12N2.ClH/c1-2-4-9(5-3-1)8-10-11-6-7-12-10;/h1-5H,6-8H2,(H,11,12);1H
危险品标志:
Xn:Harmful
风险术语:
R22;
安全术语:
S22;
分子结构式:
SDS:
查看

盐酸妥拉唑林 制备方法及用途

制备方法

生化研究。医药。

用途简介

用途

   生化研究。医药。

盐酸妥拉唑林 物化性质

外观与性状:
淡黄色结晶固体
密度:
1.09g/cm3
熔点:
172-176 °C
沸点:
338.2ºC at 760mmHg
闪点:
158.3ºC
存储条件/存储方法:
通风低温干燥
其它信息:

1.      性状:白色或乳白色结晶性粉末。有微香。味苦。

2.      密度(g/mL,25/4):未确定

3.      相对蒸汽密度(g/mL,空气=1):未确定

4.      熔点(ºC):174

5.      沸点(ºC,常压):未确定

6.      沸点(ºC,5.2kPa):未确定

7.      折射率:未确定

8.      闪点(ºC):未确定

9.      比旋光度(º):未确定

10.   自燃点或引燃温度(ºC):未确定

11.   蒸气压(kPa,25ºC):未确定

12.   饱和蒸气压(kPa,60ºC):未确定

13.   燃烧热(KJ/mol):未确定

14.   临界温度(ºC):未确定

15.   临界压力(KPa):未确定

16.   油水(辛醇/水)分配系数的对数值:未确定

17.   爆炸上限(%,V/V):未确定

18.   爆炸下限(%,V/V):未确定

19.   溶解性:易溶于水、乙醇,溶于氯仿,极微溶于乙醚和乙酸乙酯。

盐酸妥拉唑林 安全信息

海关代码:
2933290090
危险类别码:
R22
安全说明:
S22
安全标志:
S26:万一接触眼睛,立即使用大量清水冲洗并送医诊治。
:
危险标志:
Xn:Harmful;

盐酸妥拉唑林 毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NJ2350000
CHEMICAL NAME :
2-Imidazoline, 2-benzyl-, monohydrochloride
CAS REGISTRY NUMBER :
59-97-2
LAST UPDATED :
199701
DATA ITEMS CITED :
10
MOLECULAR FORMULA :
C10-H12-N2.Cl-H
MOLECULAR WEIGHT :
196.70
WISWESSER LINE NOTATION :
T5M CN BUTJ B1R &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human - infant
DOSE/DURATION :
48 mg/kg/47H-C
TOXIC EFFECTS :
Gastrointestinal - ulceration or bleeding from duodenum Gastrointestinal - ulceration or bleeding from small intestine
REFERENCE :
AUPJB7 Australian Paediatric Journal. (Royal Childrens Hospital, Parkville, Vic., Australia) V.1- 1965- Volume(issue)/page/year: 22,221,1986
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human
DOSE/DURATION :
150 ug/kg
TOXIC EFFECTS :
Cardiac - change in rate Vascular - other changes Skin and Appendages - sweating
REFERENCE :
FOMDAK Folia Medica (Naples). (Naples, Italy) V.1-57, 1915-74. Volume(issue)/page/year: 27,729,1941
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,511,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,511,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
85 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,511,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
400 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - changes in motor activity (specific assay)
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 21,1992,1971
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
130 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - changes in motor activity (specific assay)
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 21,1992,1971
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
56700 ug/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - spastic paralysis with or without sensory change Behavioral - somnolence (general depressed activity) Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
JOPHDQ Journal of Pharmacobio-Dynamics. (Japan Pub. Trading Co. (USA), 1255 Howard St., San Francisco, CA 94103) V.1- 1978- Volume(issue)/page/year: 9,395,1986 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X5567 No. of Facilities: 41 (estimated) No. of Industries: 1 No. of Occupations: 3 No. of Employees: 2093 (estimated) No. of Female Employees: 1417 (estimated)
毒理学数据:

1、急性毒性:婴儿静脉TDLo:48mg/kg、47H-C;人静脉TDLo:150ug/kg;大鼠经口LD50:1200mg/kg;大鼠腹腔LD50:100mg;

盐酸妥拉唑林 MSDS

Name: Tolazoline Hydrochloride 99% Material Safety Data Sheet
Synonym: 2-Benzyl-2-Imidazoline Hydrochloride
CAS: 59-97-2
Section 1 - Chemical Product   MSDS Name:Tolazoline Hydrochloride 99% Material Safety Data Sheet
Synonym:2-Benzyl-2-Imidazoline Hydrochloride

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
59-97-2 Tolazoline Hydrochloride 99% 200-447-3
Hazard Symbols: XN
Risk Phrases: 22

Section 3 - HAZARDS IDENTIFICATION
  EMERGENCY OVERVIEW
Harmful if swallowed.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
  Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
  General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or alcohol-resistant foam. Use agent most appropriate to extinguish fire.

Section 6 - ACCIDENTAL RELEASE MEASURES
  General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
  Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
  Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 59-97-2: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
 
Physical State: Crystalline powder
Color: white
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 174.00 - 176.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: freely soluble
Specific Gravity/Density:
Molecular Formula: C10H12N2.HCl
Molecular Weight: 196.72

Section 10 - STABILITY AND REACTIVITY
  Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
  RTECS#:
CAS# 59-97-2: NJ2350000 LD50/LC50:
CAS# 59-97-2: Oral, mouse: LD50 = 400 mg/kg; Oral, rat: LD50 = 1200 mg/kg.
Carcinogenicity:
Tolazoline Hydrochloride - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

Section 12 - ECOLOGICAL INFORMATION
 

Section 13 - DISPOSAL CONSIDERATIONS
  Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION
 
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION
 
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
Safety Phrases:
S 22 Do not breathe dust.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 59-97-2: No information available.
Canada
CAS# 59-97-2 is listed on Canada's NDSL List.
CAS# 59-97-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 59-97-2 is listed on the TSCA inventory.


SECTION 16 - ADDITIONAL INFORMATION
N/A

盐酸妥拉唑林 海关数据

中国海关编码:2933290090

概述:
2933290090. 其他结构含非稠合咪唑环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素:
品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
摘要/Summary:
2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

盐酸妥拉唑林 分子结构与计算化学数据

分子结构数据

 

1、  摩尔折射率:49.63

2、  摩尔体积(m3/mol):145.8

3、  等张比容(90.2K):370.3

4、  表面张力(dyne/cm):41.5

5、  极化率10-24cm3):19.67

计算化学数据

1、  计疏水参数计算参考值(XlogP):

2、  氢键供体数量:2

3、  氢键受体数量:2

4、  可旋转化学键数量:2

5、  互变异构体数量:

6、  拓扑分子极性表面积(TPSA):24.4

7、  重原子数量:13

8、  表面电荷:0

9、  复杂度:169

10、同位素原子数量:0

11、确定原子立构中心数量:0

12、不确定原子立构中心数量:0

13、确定化学键立构中心数量:0

14、不确定化学键立构中心数量:0

15、共价键单元数量:2

推荐供应商更多供应商>>

上海吉至生化科技有限公司

产品介绍:
产品名称:2-苄基-2-咪唑啉 盐酸盐 Cas号:59-97-2 纯度:98% 包装信息:25gea,5gea 价格:39.0元 - 123.0元
联系方式:
联系人:江珊 电话:021-57520831 手机:15316869680

北京百灵威科技有限公司

产品介绍:
产品名称:盐酸妥拉唑林 330773 Cas号:59-97-2 纯度:99% 包装信息:25g,100g,500g 价格:洽谈
联系方式:
联系人:翟先生 电话:18210857532 手机:18210857532

湖北魏氏化学试剂股份有限公司

产品介绍:
产品名称:盐酸苯甲唑啉 Cas号:59-97-2 纯度:99% 包装信息:20kg 价格:洽谈
联系方式:
联系人:张经理 电话:027-59102966 手机:18717199209

武汉沃轩科技有限公司

产品介绍:
产品名称:盐酸妥拉唑林 Cas号:59-97-2 纯度:99 包装信息:1/5/25kg 价格:0.9元
联系方式:
联系人:马经理 电话:15623499365 手机:15623499365

湖北江民泰华化工有限公司

产品介绍:
产品名称:苯甲唑啉盐酸盐 Cas号:59-97-2 纯度:99% 包装信息:25kg,200kg 价格:洽谈
联系方式:
联系人:张经理 电话:13396038321 手机:13396038321

湖北恩星生物科技有限公司

产品介绍:
产品名称:盐酸妥拉唑林 Cas号:59-97-2 纯度: 包装信息:100kg,200kg,300kg,400kg,500kg 价格:64.0元 - 100.0元
联系方式:
联系人:邵经理 电话:16621771607 手机:16621771607

武汉园星生物医药技术有限公司

产品介绍:
产品名称:盐酸妥拉唑林 Cas号:59-97-2 纯度: 包装信息:100kg,200kg 价格:0.0元 - 100.0元
联系方式:
联系人:谢 电话:027-85558552 手机:15927172400

中山朗特森生物科技有限公司

产品介绍:
产品名称:盐酸妥拉唑林 Cas号:59-97-2 纯度:99% 包装信息:1kg 价格:洽谈
联系方式:
联系人:熊小姐 电话:18064671810 手机:

范德(北京)生物科技有限责任公司

产品介绍:
产品名称:59-97-2 Cas号:59-97-2 纯度:98% 包装信息:25g 价格:396.0元
联系方式:
联系人:王 电话:15911056312 手机:15911056312

武汉鹏垒生物科技有限公司

产品介绍:
产品名称:苯甲唑啉盐酸盐 Cas号:59-97-2 纯度: 包装信息:1kg 价格:洽谈
联系方式:
联系人:何 电话:15871464247 手机:15871464247